3,4,5-Trimethoxyaniline (CAS 24313-88-0)
QUICK LINKS
3,4,5-Trimethoxyaniline (3,4,5-TMA) is an organic compound characterized by an aromatic ring adorned with three methoxy groups positioned at the 3, 4, and 5 locations. 3,4,5-Trimethoxyaniline has been extensively employed in scientific research. In the realm of organic synthesis, it acts as a building block for constructing intricate molecules. While the complete mechanism of action for 3,4,5-Trimethoxyaniline remains elusive, it is speculated to function as an agonist at specific G protein-coupled receptors. These receptors play a pivotal role in regulating diverse physiological processes like cell proliferation and differentiation. Additionally, 3,4,5-Trimethoxyaniline is believed to exert an influence on the activity of certain enzymes, including cyclooxygenase and lipoxygenase, which participate in the metabolism of fatty acids and other compounds.
3,4,5-Trimethoxyaniline (CAS 24313-88-0) References
- Synthesis, biological evaluation and molecular docking investigation of new sulphonamide derivatives bearing naphthalene moiety as potent tubulin polymerisation inhibitors. | Wang, G., et al. 2021. J Enzyme Inhib Med Chem. 36: 1402-1410. PMID: 34157927
- Discovery of Novel Diarylamide N-Containing Heterocyclic Derivatives as New Tubulin Polymerization Inhibitors with Anti-Cancer Activity. | Liu, X., et al. 2021. Molecules. 26: PMID: 34279387
- Novel Substituted Purine Isosteres: Synthesis, Structure-Activity Relationships and Cytotoxic Activity Evaluation. | Dimitrakis, S., et al. 2021. Molecules. 27: PMID: 35011476
- Discovery of Novel 3,4-Dihydro-2(1H)-Quinolinone Sulfonamide Derivatives as New Tubulin Polymerization Inhibitors with Anti-Cancer Activity. | Ma, J. and Gong, GH. 2022. Molecules. 27: PMID: 35268645
- Discovery of novel sulphonamide hybrids that inhibit LSD1 against bladder cancer cells. | Liu, J., et al. 2022. J Enzyme Inhib Med Chem. 37: 866-875. PMID: 35350943
- Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents. | Oliva, P., et al. 2022. Pharmaceutics. 14: PMID: 35745764
- Discovery and SAR analysis of phenylbenzo[d][1,3]dioxole-based proprotein convertase subtilisin/kexin type 9 inhibitors. | Li, F., et al. 2022. J Enzyme Inhib Med Chem. 37: 2017-2035. PMID: 35854672
- Discovery of dual tubulin-NEDDylation inhibitors with antiproliferative activity. | Fu, DJ. and Wang, T. 2023. J Enzyme Inhib Med Chem. 38: 166-175. PMID: 36330714
- Design, synthesis and biological evaluation of 4-aminoquinoline derivatives as receptor-interacting protein kinase 2 (RIPK2) inhibitors. | Fan, T., et al. 2023. J Enzyme Inhib Med Chem. 38: 282-293. PMID: 36408835
- Utilization of Supervised Machine Learning to Understand Kinase Inhibitor Toxophore Profiles. | Bieberich, AA. and Asquith, CRM. 2023. Int J Mol Sci. 24: PMID: 36982163
- CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents. | Peng, CM., et al. 2023. RSC Adv. 13: 13169-13176. PMID: 37124006
- A Red-Light-Responsive DASA-Polymer with High Water Stability for Controlled Release. | Ma, H., et al. 2023. Polymers (Basel). 15: PMID: 37299288
- Discovery of a New Chalcone-Trimethoxycinnamide Hybrid with Antimitotic Effect: Design, Synthesis, and Structure-Activity Relationship Studies. | Moreira, J., et al. 2023. Pharmaceuticals (Basel). 16: PMID: 37375826
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
3,4,5-Trimethoxyaniline, 10 g | sc-232042 | 10 g | $71.00 |